Five things for pharma marketers to know: Monday, February 26, 2018

FDA approves KemPharm's Apadaz; Buffett says healthcare alliance will do more than cut out middlemen; Customers unhappy with price of Teva's Syprine generic.

from Most popular articles from Medical Marketing and Media http://ift.tt/2CmKcTI